Cambridge Cognition has acquired Canadian company Winterlight Labs Inc for £7m to target a $220m market for speech-based biomarkers. Based in Toronto, Winterlight focuses on machine-learning based voice assessments, using free-speech inputs or those that require deductive reasoning or interpretation.
Winterlight Labs is an OBIO® member, CAAP® company and BDSP™ recipient.